Advances in hepatitis B therapeutics - Vicente Soriano, Pablo Barreiro, Edward Cachay, Shyamasundaran Kottilil, José V. Fernandez-Montero, Carmen de Mendoza, 2020
Sofosbuvir (Sovaldi®)
Sofosbuvir
Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus - Summers - 2014 - Journal of Pharmacy and Pharmacology - Wiley Online Library
Screen Shot 2017-01-01 at 8.20.43 PM.png
Treatment Options in Hepatitis C (09.01.2017)
Sofosbuvir - an overview | ScienceDirect Topics
Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity” - American Journal of Transplantation
Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Cav channels - ScienceDirect
Sofosbuvir/velpatasvir: A promising combination
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
Sofosbuvir and daclatasvir - Hessel - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library
Sofosbuvir - Wikipedia
What is the mechanism of action of sofosbuvir in the body? - Quora
HEPATITIS C 2014 TREATMENTS PAST AND PRESENT. - ppt video online download
Mechanism of action of therapy and therapeutic targets for... | Download Scientific Diagram
Sofsobuvir (Sovaldi) | PPT
Advances in newly developing therapy for chronic hepatitis C virus infection
Sofsobuvir (Sovaldi) | PPT
An Integrated BioSci Research On Gilead Sciences - Why The Sovaldi China Expansion Will Deliver Gargantuan Growth? (NASDAQ:GILD) | Seeking Alpha
Ehrung für Virus-Erforscher
Sofosbuvir - Wikipedia
The ProTide Prodrug Technology: From the Concept to the Clinic | Journal of Medicinal Chemistry
